planned administration/ administration of a vaccine not foresee by the study protocol within 30 day prior to until 42 day after the study vaccine dose with the exception of inactivate vaccine such a pneumococcal haemophilus influenzae type b conjugate vaccine inactivate influenza hepatitis a or b vaccine or diphtheria/tetanus-containing vaccine which can be administer up to eight day before the study vaccine dose 